Dermatology

Interchangeability and Pharmacy-Level Substitution

Array

Activity Info

Upon completion of the activity, participants should be able to:
1. Summarize key aspects of current and proposed regulations regarding interchangeability and pharmacist-level substitution with biosimilars
2. Access information on approved biosimilars to determine if pharmacy-level substitution will be applicable
Email

CME/CE credit is no longer available for this activity.

Tags

Webinar | Oncology | 0.25 - 15 mins | Dermatology | Gastroenterology | Hematology | Internal Medicine | Rheumatology | Family Medicine | Nurse | Biosimilars | BiosimilarsCME.org | Online | Pharmacist |